GlassScriptPhysician profile
Lynn M Oconnor
NPI 1689601767
$63,240.89
in general payments reported to CMS, 2019-2025
16 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $3,887 · 2021: $33.49 · 2022: $1,621 · 2023: $361 · 2024: $706 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,095 · Travel and Lodging: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,094.68 |
| Travel and Lodging | $222.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $60,277.38 | 2019-2022 | |
| Ethicon INC. | $757.50 | 2020 | |
| Medtronic, INC. | $603.48 | 2022-2024 | Interstim |
| Dilon Technologies, INC. | $552.75 | 2023-2025 | Hemoblast Bellows |
| Axonics, INC. | $288.32 | 2023-2024 | Axonics |
| Intuitive Surgical, INC. | $186.59 | 2019-2024 | |
| Ethicon US, LLC | $169.02 | 2019-2024 | Echelon Circular, Echelon Flex, Proximate |
| Aroa Biosurgery Incorporated | $104.22 | 2022 | |
| Ferring Pharmaceuticals INC. | $94.48 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.03 | 2022-2024 | Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.41 | 2019 | |
| Abbvie INC. | $41.13 | 2019 | |
| Innovation Technologies INC | $19.95 | 2025 | Irrisept |
| Braintree Laboratories, INC. | $13.95 | 2019 | |
| Integra Lifesciences Corporation | $12.61 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10.07 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Oconnor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.